BackBeauty Health Company (The) - Warrants (04/05/2026) Overview

Beauty Health Company (The) - Warrants (04/05/2026) Receivables

Track Beauty Health Company (The) - Warrants (04/05/2026)'s receivables ($38M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$38.39M

Peer average

Loading

Beauty Health Company (The) - Warrants (04/05/2026) Receivables History

Loading

Beauty Health Company (The) - Warrants (04/05/2026) vs. peers: Receivables Comparison

Loading

Beauty Health Company (The) - Warrants (04/05/2026) Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Beauty Health Company (The) - Warrants (04/05/2026) (SKINW) FAQ

As of the most recent data (September 2021), SKINW shows a receivables of $38M. Scroll down for historical charts and peer comparison views.

Tracking SKINW's receivables over time shows whether Beauty Health Company (The) - Warrants (04/05/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $38M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Beauty Health Company (The) - Warrants (04/05/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $38M) with ownership activity and broader fundamentals.

Beauty Health Company (The) - Warrants (04/05/2026)'s receivables is $38M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.